New York City, NY -- (SBWIRE) -- 10/09/2013 -- StockMarketIntel.com issues a special report on the following stocks: CEL-SCI Corporation (NYSEMKT:CVM), Yahoo! Inc. (NASDAQ:YHOO), MannKind Corporation (NASDAQ:MNKD), Roche Holding Ltd. (ADR) (OTCMKTS:RHHBY)
CEL-SCI Corporation (NYSEMKT:CVM) declined -32.34%, trading on 8.29 million shares, to end the trade at $0.839. If we look at its trading history of the past 52 weeks, the share price suffered a low of $0.83 and was moved to the maximum level of $3.89. The stock changed hands in a range of $0.83 to $0.92, bringing its market capitalization to about $26 million. CEL-SCI Corporation (CEL-SCI) is engaged in the business of Multikine cancer therapy; New cold fill manufacturing service to the pharmaceutical industry, and ligand epitope antigen presentation System (LEAPS) technology, with two products, hemagglutinin type 1 and neuraminidase type 1 (H1N1) swine flu treatment for H1N1 hospitalized patients and CEL-2000, a rheumatoid arthritis treatment vaccine.
Will CVM Bounce Back After yesterday’s Sharp Sell off? Find Out Here
Yahoo! Inc. (NASDAQ:YHOO) declined -3.54%, to complete the trading session at $32.93, with a total volume of 42.91 million shares. The stock, on average, trades on a volume of 17.79 million shares. In the past 52 weeks, the share price has not declined below $15.65 and above $35.06. It floated in a range of $32.10 to $34.50 during the last trading session, with a beta value of 0.87. Its market capitalization now moved to about $33.60 billion. Yahoo! Inc. (Yahoo!) is a digital media company. Through the Company’s technology and insights, Yahoo! delivers digital content and experiences, across devices and globally. Yahoo!provides online properties and services (Yahoo! Properties) to users, as well as a range of marketing services designed to reach and connect with those users on Yahoo! and through a distribution network of third-party entities (Affiliates).
Is it the Right to Grab YHOO after the Recent Slump? Get Free Trend Analysis Here
MannKind Corporation (NASDAQ:MNKD) recorded a fall of -7.51% and was in a range of $4.65-$5.06 before closing at $4.68. The share price hit its 52-week low of $1.82 and $8.70 was the best price. The stock completed the day with a total volume of 9.25 million shares, versus an average volume of 5.04 million shares. MannKind Corporation (MannKind) is a development-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapeutic products for diseases such as diabetes and cancer. The Company’s product candidate, AFREZZA (insulin human) inhalation powder, is insulin that is in late-stage clinical investigation for the treatment of adults with type I or type II diabetes for the control of hyperglycemia.
Will MNKD Reach the Bottom after Yesterday’s Correction? Find Out Here
Roche Holding Ltd. (ADR) (OTCMKTS:RHHBY) declined -1.15% yesterday, bringing its market capitalization around $223.09 billion. The total number of shares that changed hands during the session was 583,929shares, as compared to average trading volume of 585,847 shares. The share price, after opening at $65.50, made a high of $65.59 and hovered above $64.66 to end the day at $64.66. Roche Holding AG is a Swiss pharmaceuticals and diagnostics holding company. It belongs to the Roche Group that operates through subsidiaries and associated companies around the world. It discovers, develops and provides diagnostic and therapeutic products and services from early detection and prevention of diseases to diagnosis, treatment and treatment monitoring.
Has RHHBY Found The Bottom and Ready To Move Up? Find Out Here
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)